CAPITOL HEALTH LIMITED (CAJ)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CAJ - CAPITOL HEALTH LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 3.36
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.225

17 Apr
2024

0.000

OPEN

$0.23

0.000

HIGH

$0.23

34,543

LOW

$0.23

TARGET
$0.315 40.0% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
ACL . AHX . ALC . BMT . DOC . EBO . HLS . M7T . MDR . MPL . MVF . NHF . PSQ . RHC . SHL .
FNARENA'S MARKET CONSENSUS FORECASTS
CAJ: 1
Title FY22
Actual
FY23
Actual
FY24
Forecast
FY25
Forecast
EPS (cps) xxx N/A 0.9 xxx
DPS (cps) xxx N/A 1.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 26.5 xxx
Dividend Yield xxx N/A 4.4% xxx
Div Pay Ratio(%) xxx N/A 117.6% xxx

Dividend yield today if purchased 3 years ago: 2.70%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

4.44

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 06/03 - ex-div 0.5c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-1.1
DPS All xxxxxxxxxxxxxxx1.0
Sales/Revenue xxxxxxxxxxxxxxx209.6 M
Book Value Per Share xxxxxxxxxxxxxxx12.9
Net Operating Cash Flow xxxxxxxxxxxxxxx37.5 M
Net Profit Margin xxxxxxxxxxxxxxx-5.44 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-7.85 %
Return on Invested Capital xxxxxxxxxxxxxxx-4.70 %
Return on Assets xxxxxxxxxxxxxxx-3.87 %
Return on Equity xxxxxxxxxxxxxxx-7.85 %
Return on Total Capital xxxxxxxxxxxxxxx6.08 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx10.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx12 M
Long Term Debt xxxxxxxxxxxxxxx123 M
Total Debt xxxxxxxxxxxxxxx135 M
Goodwill - Gross xxxxxxxxxxxxxxx157 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx19 M
Price To Book Value xxxxxxxxxxxxxxx2.09

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx16.8 M
Capex % of Sales xxxxxxxxxxxxxxx8.04 %
Cost of Goods Sold xxxxxxxxxxxxxxx172 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx22 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx2 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

01/03/2024

1

Buy

$0.31

37.78%

Capitol Health has reported a 20% year-on-year revenue increase over the first half to $118m, while adjusted earnings increased 22% to $24m and adjusted net profits increased 6% to $5m.

According to Ord Minnett, operating trends are improving and profitability jaws widening for the company. The broker points out the company continues to invest in higher end modalities, and believes this makes Capitol Health a more attractive target within the sector.

The Buy rating is retained and the target price increases to 31 cents from 30 cents.

FORECAST
Ord Minnett forecasts a full year FY24 dividend of 1.00 cents and EPS of 0.70 cents.
Ord Minnett forecasts a full year FY25 dividend of 1.00 cents and EPS of 1.30 cents.

CAJ STOCK CHART